Dyax Corp Profile

USD 38.41  9,223,372,036,855%

Acquisition by David McLachlan of 50000 shares of Dyax Corp subject to Rule 16b-3

Dyax Corp insider trading alert for grant of stock option (right to buy) by David McLachlan, the corporate stakeholder, on May 17, 2018. This event was filed by Dyax Corp with SEC on 2015-05-14. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Dyax Corp Summary

Dyax Corp (DYAX) is traded on NASDAQ General Markets in USA. It is located in MASSACHUSETTS, U.S.A and employs 124 people. Dyax Corp is listed under Business Services category by Fama And French industry classification.The company currently falls under '' category with current market capitalization of 0. Dyax Corp has 133.37 M outstanding shares of which 4.77 M shares are currently shorted by private and institutional investors with about 0.0 trading days to cover. DYAX CORP currently holds about 20.49 M in cash with (8.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.1.
Check Dyax Corp Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 38.41HorizonTargetOdds Above 38.41
72.46%30 days 38.41 27.48%
Based on normal probability distribution, the odds of Dyax Corp to move above current price in 30 days from now is about 27.48% (This Dyax Corp probability density function shows the probability of Dyax Corp Stock to fall within a particular range of prices over 30 days) .

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Primecap Management CoCommon Shares10.5 M31.4 M
Tiaa Cref Investment Management LlcCommon Shares467.8 K519 K
View Dyax Corp Diagnostics

Selected Dyax Corp Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Dyax Corp Against Markets

Current Ratings

Dyax Corp 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Dyax Corp are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Dyax Corporation, a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema and other plasmakallikreinmediated disorders.. The public information regarding Dyax Corp's current market price is not available at this time.
Fama & French Business Services
Business Services
Fama & French Classification
NameDyax Corp
CEO and President and DirectorGustav ChristensenView All
Thematic Classification
Currently Active Investing Idea
  Business Services
View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressBurlington, MA
ExchangeNASDAQ General Markets
IndustryBusiness Services
Contact Number617 225 2500
CurrencyUSD - US Dollar

Did you try this?

Run Bollinger Bands Now

Bollinger Bands

Use Bollinger Bands indicator to analyze target price for a given investing horizon
All  Next Launch Bollinger Bands


Dyax Corp Analyst Recommendations
Target PriceAdvice# of Analysts
Dyax Corp current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Dyax Corp Analyst Advice  


Dyax Corp Corporate Directors
Thomas Kempner Independent Director
Jennifer Robinson Associate Director, Investor Relations and Corporate Communications
James Fordyce Independent Director
Additionally see Investing Opportunities. Please also try Aroon Oscillator module to analyze current equity momentum using aroon oscillator and other momentum ratios.